Original Articles: Mechanisms of Allergy
Increased total serum IgE levels in patients with asthma and promoter polymorphisms at CTLA4 and FCER1B

https://doi.org/10.1067/mai.2001.116119Get rights and content

Abstract

Background: Increasing evidence indicates that total serum IgE levels are largely determined by genetic factors, and we recently established that the –109C/T promoter polymorphism at FCER1B is a genetic factor that affects total serum IgE levels. The gene encoding cytotoxic T lymphocyte antigen 4 (CTLA4) is another candidate factor in high IgE responsiveness, because B7-CD28/CTLA4 interaction can promote the differentiation and development of the TH2 lymphocyte subset. Objective: We intended to determine whether CTLA4 is associated with increased levels of total serum IgE or with the development of asthma or atopy. Methods: We performed a case-control study involving 339 patients with asthma and 305 healthy control subjects, of whom 226 of the patients with asthma and 219 of the healthy control subjects had previously been genotyped for the –109C/T promoter polymorphism at FCER1B. In the current study, we genotyped 2 polymorphisms in the CTLA4 gene, one involving the promoter (–318C/T) and the other involving exon 1 (+49A/G), in addition to the FCER1B promoter polymorphism. Results: Patients with asthma who were homozygous for the –318C allele at the CTLA4 promoter region had higher levels of total serum IgE than patients with asthma carrying the –318T allele (P = .00470). The analysis of –318C/T (at CTLA4) and –109C/T (at FCER1B) promoter polymorphisms showed a significant correlation between the combined genotypes and increased levels of total IgE in patients with asthma (P = .000014). In contrast, no correlation between total serum IgE levels and –318C/T or +49A/G genotypes was detected in 305 healthy control subjects. There was no evidence indicating an association between a putative allele for asthma or atopy and alleles at any of the CTLA4 polymorphic loci. Conclusion: Our findings suggest that promoter polymorphisms of both CTLA4 and FCER1B are genetic factors that influence total serum IgE levels in patients with asthma. This supports the theory that variance in total serum IgE levels in patients with asthma is determined by mutations in multiple genes, each of which has a relatively small effect on the phenotype. (J Allergy Clin Immunol 2001;108:74-9.)

References (0)

Cited by (66)

  • rhPLD2 inhibits airway inflammation in an asthmatic murine model through induction of stable CD25 <sup>+</sup> Foxp3 <sup>+</sup> Tregs

    2018, Molecular Immunology
    Citation Excerpt :

    These results suggest that rhPLD2 specifically suppresses airway eosinophil infiltration (Fig. 2A). Atopic allergies, including atopic (allergic) asthma and atopic dermatitis, are characterized by increased local and systemic production of IgE which can mediate AHR (Amit et al., 2014; Hizawa et al., 2001). The high IgE production is the result of high Th2 polarization in T cell responses.

  • Association of three sets of high-affinity IgE receptor (FcepsilonR1) polymorphisms with aspirin-intolerant asthma

    2008, Respiratory Medicine
    Citation Excerpt :

    Although, we identified significant associations between the FCER1A-95T>C polymorphism and serum IgE specific for SEA and TSST-1, further studies using a larger sample size are necessary to confirm these associations. Previous population studies have reported significant associations between the MS4A2 polymorphism and total serum IgE levels in asthmatic patients.27,28 However, our results suggest that this is not the case for AIA patients.

  • Allergen-Specific IgG1 Provides Parsimonious Heritability Estimates for Atopy-Associated Immune Responses to Allergens

    2007, Human Immunology
    Citation Excerpt :

    Recent evidence suggests that single nucleotide polymorphisms (SNPs) in the promoter regions of immune regulatory genes can profoundly impact upon the specific details of an immune response to allergens [36]. Three specific examples include SNPs in the CD14 endotoxin receptor gene that influences both allergen-specific IgE and IgG1 production among those with atopy [37], SNPs in the promoter region for inducible cofactor of stimulation that mediates T cell–B cell interaction during humoral response development [38], and CTLA-4 gene promoter SNPs that also impacts upon T cell–B cell interaction [39, 40]. Given that each of these gene promoter elements can have at least one of three genotypes (e.g., C/C, C/T, or T/T for the CD14 promoter), then there are at least 3 × 3 × 3 = 27 possible combinations taking all three together.

  • Stress and allergic diseases

    2007, Psychoneuroimmunology, Two-Volume Set
  • Cluster Analysis Identifies 3 Phenotypes within Allergic Asthma

    2018, Journal of Allergy and Clinical Immunology: In Practice
    Citation Excerpt :

    Thus, although in both clusters IgE is a key etiopathogenic factor, as evident by positive specific IgE or skin prick testing and symptoms on exposure to the allergen, it is tempting to speculate that in cluster 1 the effect of environmental influences could be more evident than that of genetic influences, whereas in cluster 2 it could be the other way around. In this sense, associations between total serum IgE and polymorphisms of different genes have been described.23-25 This could be reflected in the higher levels of total serum IgE observed in cluster 2, in which genetic influences are purportedly stronger.

View all citing articles on Scopus

Supported in part by a Grant-in-Aid for Scientific Research (10307013 and 11670559) from the Japanese Ministry of Education, Science, Sports and Culture.

View full text